Yayınlar & Eserler

Makaleler 146
Tümü (146)
SCI-E, SSCI, AHCI (120)
SCI-E, SSCI, AHCI, ESCI (130)
ESCI (10)
Scopus (134)
TRDizin (15)
Diğer Yayınlar (6)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 100

1. Development of thiazole-hydrazone hybrids for targeted therapy of non-small cell lung cancer Activity

EFMC-ASMC International Symposium on Advances in Synthetic and Medicinal Chemistry, Porto, Portekiz, 31 Ağustos - 04 Eylül 2025, ss.368, (Özet Bildiri)

2. A NEW SERIES OF TETRAZOLE-HYDRAZONE HYBRIDS ENDOWED WITH ANTICANDIDAL ACTIVITY

EFMC-ASMC International Symposium on Advances in Synthetic and Medicinal Chemistry, Zagreb, Hırvatistan, 3 - 07 Eylül 2023, ss.271, (Özet Bildiri) Creative Commons License

3. A New Series of Hydrazone-Based Anti-Inflammatory Agents Endowed with Selective COX-1 Inhibitory Potency

EFMC-ASMC International Symposium on Advances in Synthetic and Medicinal Chemistry, Zagreb, Hırvatistan, 3 - 07 Eylül 2023, ss.95, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma

4. A series of 2-pyrazolines endowed with potent anticandidal activity

7th Congress of Pharmacy in North Macedonia with international participation, Ohrid, Makedonya, 5 - 09 Ekim 2022, cilt.68, ss.419-420, (Tam Metin Bildiri)

5. A new series of chalcones endowed with potent anticancer activity towards A549 cells

7th Congress of Pharmacy in North Macedonia with international participation, Ohrid, Makedonya, 5 - 09 Ekim 2022, cilt.68, ss.399-400, (Tam Metin Bildiri)

7. A new series of EGFR-targeted antitumor agents against non-small cell lung cancer

A new series of EGFR-targeted antitumor agents against non-small cell lung cancer, Burdur, Türkiye, 29 Eylül 2021, (Özet Bildiri) Sürdürülebilir Kalkınma

8. New Imidazothiazole-Hydrazone Hybrids as Potent EGFR-Targeted Anticancer Agents

V. International Joint Science Congress of Materials and Polymers (ISCMP), Burdur, Türkiye, 29 Eylül 2021, (Özet Bildiri)

10. A new series of chalcones as potent cathepsin D and L inhibitors

XXXI. Türk Biyokimya Derneği Ulusal Biyokimya Kongresi, 18 Aralık 2020, (Özet Bildiri)

15. In Silico Evaluation of A Series of Furan-based Hydrazones as Lanosterol 14α-Demethylase Inhibitors

55th International Conference on Medicinal Chemistry, Nantes-France, 3 - 05 Temmuz 2019, (Özet Bildiri)

16. In Silico Studies on A Series of Thiosemicarbazone-based COX Inhibitors

55th International Conference on Medicinal Chemistry, Nantes-France, 3 - 05 Temmuz 2019, (Özet Bildiri)

17. In Vitro Evaluation of A New Series of Bis-Pyrazolines as Antifungal Agents

11th Joint Meeting on Medicinal Chemistry 2019, Prague-Czech Republic, 27 - 30 Haziran 2019, (Özet Bildiri)

18. New Pyrazoline Derivatives Clubbed with Thiazole Scaffold as Anticancer Agents Targeting EGFR

11th Joint Meeting on Medicinal Chemistry 2019, Prague-Czech Republic, 27 - 30 Haziran 2019, (Özet Bildiri)

19. New Thiazolyl-Pyrazoline Derivatives as Antibacterial Agents

ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

20. The Antimicrobial and Genotoxic Effects of A New Series of Quinoxaline-Based Hydrazones

The 5th International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS-5), Cappadocia-Turkey, 26 - 28 Nisan 2019, (Özet Bildiri)

21. A New Series of Morpholine-Based Thiazolyl-Pyrazolines as Dual EGFR and HER2 Inhibitors

The 5th International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS-5), Cappadocia-Turkey, 26 - 28 Nisan 2019, (Özet Bildiri)

22. Design, Synthesis and In Vitro Evaluation of New Triazolothiadiazine Derivatives as Potential Antitumor Agents

The 5th International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS-5), Cappadocia-Turkey, 26 - 28 Nisan 2019, (Özet Bildiri)

23. In Vitro and In Vivo Evaluation of A New Series of Thiosemicarbazones as Potential Anti-Inflammatory Agents

The 5th International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS-5), Cappadocia-Turkey, 26 - 28 Nisan 2019, (Özet Bildiri)

24. Antiproliferative Effects of a Series of Pyrazolines on Lung Cancer

2nd International Cell Death Research Congress-Turkey (3rd Congress of Cell Death Research Society-TURKEY), Izmir-TURKEY, 1 - 04 Kasım 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

26. Synthesis and Antioxidant Activities of A New Series of 1,3,4-Oxadiazole Derivatives

XXII International Conference on Organic Synthesis – 22-ICOS, Florence-ITALY, 16 - 21 Eylül 2018, (Özet Bildiri)

27. Design, Synthesis and Evaluation of A New Series of Bis-Pyrazoline Derivatives as Potential Antioxidant Agents

XXII International Conference on Organic Synthesis – 22-ICOS, Florence-ITALY, 16 - 21 Eylül 2018, (Özet Bildiri)

28. In Vitro and In Silico Studies on The Mosquitocidal Activity of A Series of Piperidine Derivatives against Aedes aegypti

Italian-Spanish-Portuguese Joint Meeting in Medicinal Chemistry MedChemSicily2018, Palermo-ITALY, 17 - 20 Temmuz 2018, (Özet Bildiri)

29. Synthesis and In Vitro Studies of A New Series of Thiosemicarbazones as Anticancer Agents

Italian-Spanish-Portuguese Joint Meeting in Medicinal Chemistry MedChemSicily2018, Palermo-ITALY, 17 - 20 Temmuz 2018, (Özet Bildiri)

30. Synthesis and Neuroprotective Effects of New Pyrazoline Derivatives

Italian-Spanish-Portuguese Joint Meeting in Medicinal Chemistry MedChemSicily2018, Palermo-ITALY, 17 - 20 Temmuz 2018, (Özet Bildiri)

31. Synthesis, In Vitro and In Silico Studies of New Pyrazoline Derivatives as Potential Anticandidal Agents

ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

32. New Thiazole Derivatives as Potential Aldose Reductase Inhibitors

ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

33. Synthesis and Evaluation of New Benzazole Derivatives as Potential Anticandidal Agents

ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

34. Synthesis, In Vitro and In Silico Studies of A Series of 1,3,4-Oxadiazoles as FAK Inhibitors

ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

35. Synthesis and Evaluation of New Pyrazoline Derivatives as Antibacterial Agents

ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

36. In Vitro and In Silico Studies of A Series of 1,3,4-Thiadiazoles as Acetylcholinesterase Inhibitors

ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

37. Synthesis, In Vitro and In Silico Studies of A Series of Dithiocarbamate Derivatives as Anticandidal Agents

ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

38. Neuroprotective Effects of Some Pyrazoline Derivatives Against 6-OHDA Induced Neurodegeneration

ISOPS 12th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

39. Synthesis and evaluation of a series of pyrazoline derivatives as potential neuroprotective agents

the 4rd International Conference on Applied Biological Sciences (ICABS 2018), Eskişehir, Türkiye, 3 - 05 Mayıs 2018, (Özet Bildiri)

40. Synthesis and Evaluation of New Pyrrole Derivatives as Selective Human MAO Inhibitors

5th International BAU Drug Design Congress, İstanbul, Türkiye, 19 - 21 Ekim 2017, (Özet Bildiri)

41. Design, Synthesis and Evaluation of New Oxadiazole Derivatives as Potential Akt Inhibitors

5th International BAU Drug Design Congress, İstanbul, Türkiye, 19 - 21 Ekim 2017, (Özet Bildiri)

42. Design, Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticandidal Agents

5th International BAU Drug Design Congress, İstanbul, Türkiye, 19 - 21 Ekim 2017, (Özet Bildiri)

43. Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticandidal Agents

5th International BAU Drug Design Congress, İstanbul, Türkiye, 19 - 21 Ekim 2017, (Özet Bildiri)

44. Design, Synthesis and Evaluation of New Thiazolyl-Pyrazoline Derivatives as Potential Anticandidal Agents

2nd International Gazi Pharma Symposium (2nd GPSS 2017), Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

45. Synthesis and Evaluation of New Thiazole Derivatives as Potential Anticancer Agents Targeting AKT

2nd International Gazi Pharma Symposium (2nd GPSS 2017), Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

46. Synthesis and Evaluation of A Series of Arylidene Indanones as New Antitumor Agents

2nd International Gazi Pharma Symposium (2nd GPSS 2017), Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

47. Synthesis and Evaluation of A New Series of Thiazoles as Anticholinesterase Agents

2nd International Gazi Pharma Symposium (2nd GPSS 2017), Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

48. Synthesis and Inhibitory Effects of New Chalcone Derivatives on A549 Cells

6th Pharmaceutical Sciences World Congress 2017 (FIP PSWC 2017), Stockholm, İsveç, 21 - 24 Mayıs 2017, (Özet Bildiri)

49. Pharmacist’s Role in Food Supplements for Public Health

6th Pharmaceutical Sciences World Congress 2017 (FIP PSWC 2017), Stockholm, İsveç, 21 - 24 Mayıs 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

50. Pharmacy Students’ Perceptions on Pharmaceutical Promotion

6th Pharmaceutical Sciences World Congress 2017 (FIP PSWC 2017), Stockholm, İsveç, 21 - 24 Mayıs 2017, (Özet Bildiri)

51. The Problems of Healthcare System in Turkey

IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

53. Medya ve İlaç

IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

54. The Problem of Healthcare System in Turkey

IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

55. Synthesis, Evaluation of New Chalcone Derivatives as Potential Anticholinesterase Agents and Docking Studies

IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

56. Eczacıların Farmakoinformatiği Kullanma Amaçları

IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

57. An Approach of Turkish Pharmaceutical Industry to Biotechnological and Biosimilar Drugs

IVEK 3rd International Convention of Pharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

58. Anticholinesterase Effects of Some Triazole Derivatives

The 13th International Conference on Alzheimer’s Parkinson’s Diseases (AD/PD 2017), Viyana, Avusturya, 29 Mart - 02 Nisan 2017, (Özet Bildiri)

59. A Series of Imidazole Derivatives as New Anticholinesterase Agents

The 13th International Conference on Alzheimer’s Parkinson’s Diseases (AD/PD 2017), Viyana, Avusturya, 29 Mart - 02 Nisan 2017, (Özet Bildiri)

60. Pirazolin türevlerinin antikandidal etkilerinin araştırılması

13. Türkiye Eczacılık Kongresi, İstanbul, Türkiye, 21 - 24 Aralık 2016, (Özet Bildiri)

62. Synthesis and Antimycobacterial Activity of 5-Arylfurfural N-(2,4 difluorophenyl)thiosemicarbazone Derivatives

4th International BAU-Drug Design Congress, İstanbul, Türkiye, 13 - 15 Ekim 2016, (Özet Bildiri)

63. Synthesis and Evaluation of A New Series of Pyrazoline Derivatives as Potent Antitumor Agents Against HepG2 Cells

XXIV National Meeting on Medicinal Chemistry and 10th Young Medicinal Chemists’ Symposium, 11 - 14 Eylül 2016

64. Synthesis of Novel Thiazole Derivatives and Evaluation of Their Cytotoxic Effects on A549 Cells

XXIV National Meeting on Medicinal Chemistry and 10th Young Medicinal Chemists’ Symposium, 11 - 14 Eylül 2016

72. Anticancer Activity of Synthesized Pyrazoline Derivatives

BMB2015 Biochemistry and Molecular Biology, Kobe Port Island, Japonya, 1 - 04 Aralık 2015

73. Some thiazole derivatives as new anticancer agents

XXIII National Meeting on Medicinal Chemistry, Salerno, İtalya, 6 - 09 Eylül 2015

74. Synthesis of Some Morpholine Derivatives as New Anticancer Agents

5th Meeting of the Paul Ehrlich MedChem Euro-PhD Network, Krakow, Polonya, 3 - 05 Temmuz 2015

75. MAO Inhibitory Effects of Some Pyrazoline Derivatives

5th Meeting of the Paul Ehrlich MedChem Euro-PhD Network, Krakow, Polonya, 3 - 05 Temmuz 2015

77. Synthesis of some furan substituted pyrazoline derivatives as new anticancer agents

16th Blue Danube Symposium on Heterocyclic Chemistry, Balatonalmadi, Macaristan, 14 - 17 Haziran 2015

78. Synthesis of new thiazole based anticancer agents against MCF 7 human breast adenocarcinoma cells

11th International Symposium on Pharmaceutical Sciences (ISOPS11), Ankara, Türkiye, 9 - 12 Haziran 2015

79. Synthesis and antimicrobial activity of some furan based thiosemicarbazone derivatives

11th International Symposium on Pharmaceutical Sciences (ISOPS11), Ankara, Türkiye, 9 - 12 Haziran 2015

81. Thiazole Based Anticholinesterase Agents

XXIII National Meeting on Medicinal Chemistry, 6 - 09 Eylül 2015

84. Pharmacy Technicians from the Perspective of Pharmacists in Eskişehir

12. Türkiye Eczacılık Kongresi, Ankara, Türkiye, 25 - 27 Eylül 2014, (Özet Bildiri)

85. A Mini-survey on Pharmacy Technicians in Eskişehir

12. Türkiye Eczacılık Kongresi, Ankara, Türkiye, 25 - 27 Eylül 2014, (Özet Bildiri)

86. Synthesis and Biochemical Mechanisms of Bisthiazole Derivatives Action

Fourth International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-2014), İstanbul, Türkiye, 18 - 21 Eylül 2014

87. Synthesis and evaluation of thiazole-based oxadiazole derivatives as potential anticancer agents

MCB2014 Joining forces in pharmaceutical analysis and medicinal chemistry, Groningen, Hollanda, 25 - 26 Ağustos 2014, (Özet Bildiri)

88. Synthesis and anticandidal activity of new thiazole derivatives

International Union of Microbiological Societies Congresses (IUMS 2014), Montreal, Kanada, 27 Temmuz - 01 Ağustos 2014

89. Synthesis and In Vıvo Evaluation of 1 3 5 Trisubstituted Pyrazolines As Antidepressant like Agents

20th International Conference on Organic Synthesis (ICOS-20), Budapest, Macaristan, 29 Haziran - 04 Temmuz 2014

90. Chloro Substituted Pyrazolines As Antidepressant Agents

20th International Conference on Organic Synthesis (ICOS-20), Budapest, Macaristan, 29 Haziran - 04 Temmuz 2014

94. Studies on Pyrazoline Derivatives as Antimicrobial Agents

10 th International Symposium on Pharmaceutical Sciences (ISOPS), 26 - 29 Haziran 2012, (Özet Bildiri)

96. Bazı Tiyazol Türevlerinin Sentezi ve Antikolinesteraz Aktiviteleri

XXIII. Ulusal Biyokimya Kongresi, Adana, Türkiye, 29 Kasım - 02 Aralık 2011, cilt.36, (Özet Bildiri)

97. Synthesis and Antimicrobial Activity of 1,2,4-Triazine Derivatives

45th International Conference on Medicinal Chemistry, Orleans, Fransa, 1 - 03 Temmuz 2009, (Özet Bildiri)

98. The New Imidazol1,2-a) Pyrazine-2-Carboxylic Acid Arylidene-Hydrazid Derivatives and Their Antimicrobial Activity

International Symposium on Medicinal Chemistry Research and Development 2005, 28 Eylül - 01 Ekim 2005, (Özet Bildiri)

99. Synthesis and Antimicrobial Activities of Some 1-( α -(N,N Disubstitutedaminothiocarbonylthio)acetyl)-3,5-Diphenyl-2-Pyrazolines

International Symposium on Pharmaceutical Chemistry, Proceedings, 327-328, İstanbul, (2003)., 17 - 19 Eylül 2003, (Özet Bildiri)
Kitaplar 7

1. Nonsteroidal Anti-inflamatuvar İlaçlar

Eczacılık Fakültesi Farmasötik Kimya Akıl Notları, ŞİMŞEK RAHİME, Editör, Güneş Tıp Kitabevleri Ltd. Şti., Eskişehir, ss.435-488, 2025

2. Sağlık Hizmetlerinde Etik

Sağlık Bilimlerinde ve Yönetiminde Etik, DEMİRCİ FATİH, Editör, Anadolu Üniversitesi Yayınları, Eskişehir, ss.31-59, 2024

3. Hasta Hakları ve Etik

Sağlık Bilimlerinde ve Yönetiminde Etik, DEMİRCİ FATİH, Editör, Anadolu Üniversitesi Yayınları, Eskişehir, ss.60-88, 2024

4. Sağlık İşletmelerinde Motivasyon - Bölüm 7

Sağlık İşletmelerinde Davranış, AHMET ÖZDEMİR, Editör, ANADOLU ÜNİVERSİTESİ YAYINLARI, Eskişehir, ss.176-213, 2020

5. Sağlık ve Biyomedikal Etiği - Ünite 5

Sağlık Bilimlerinde ve Yönetiminde Etik, Demirci Fatih, Editör, Anadolu Üniversitesi, Eskişehir, ss.116-141, 2019

6. İlacın Tarihçesi

Temel İlaç Bilgisi ve Akılcı İlaç Kullanımı, Kaplancıklı Zafer Asım, Editör, Anadolu Üniversitesi, Eskişehir, ss.2-25, 2016

7. İlaç Hammadde Kaynakları ve Üretim Standartları

Temel İlaç Bilgisi ve Akılcı İlaç Kullanımı, Kaplancıklı Zafer Asım, Editör, Anadolu Üniversitesi, Eskişehir, ss.26-58, 2016
Metrikler

Yayın

262

Yayın (WoS)

131

Yayın (Scopus)

135

Atıf (WoS)

3533

H-İndeks (WoS)

33

Atıf (Scopus)

3984

H-İndeks (Scopus)

36

Atıf (Scholar)

4063

H-İndeks (Scholar)

38

Atıf (Sobiad)

10

H-İndeks (Sobiad)

1

Proje

50

Fikri Mülkiyet

2

Tez Danışmanlığı

2

Açık Erişim

27
BM Sürdürülebilir Kalkınma Amaçları